SGRY vs NHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SGRY · Surgery Partners$23.20 ▲ 0.13%
NHC · National Healthcare$208.85 ▲ 0.59%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SGRY +44.7%
- NHC +62.1%
Head to head
| Metric | SGRY | NHC |
|---|---|---|
| Price | $23.20 | $208.85 |
| Change today | ▲ 0.13% | ▲ 0.59% |
| Market cap | $2.99B | $3.27B |
| Return, 3 months | +45.5% | -5.2% |
| Return, year to date | +50.2% | +53.9% |
| Return, 1 year | +7.9% | +66.7% |
| P/E (TTM) | – | 28.9 |
| P/B | 1.8 | 2.9 |
| P/E percentile vs own 5y | 61st | 57th |
| Dividend yield | – | 1.25% |
| Revenue growth (YoY, latest qtr) | +2.7% | +8.8% |
| Net profit growth (YoY) | -33.9% | +68.1% |
| Gross margin | 22.5% | 39.5% |
| Operating margin | 13.7% | 9.3% |
| Net margin | -2.6% | 9.0% |
| Return on equity | -5.2% | 13.1% |
| Analyst target vs. price | -10.0% | – |
| Analyst buy share | 22% | – |
| RSI (14) | 85 | 41 |
| 30-day volatility | 116.1% | 41.7% |
| Max drawdown, 1 year | -49.9% | -18.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NHC is the largest of the group by market value.
- NHC has returned the most over the past year.
- NHC is growing revenue fastest.
- NHC keeps the most profit per dollar of sales.
- NHC has been the calmest stock over the last 30 days.